Literature DB >> 2635740

Availability predictions by hepatic elimination models for Michaelis-Menten kinetics.

M S Roberts1, J D Donaldson, D Jackett.   

Abstract

Numerical methods have been used to compare the availability predictions of a number of hepatic elimination models when Michaelis-Menten kinetics is operative. Propranolol and galactose were used as model compounds. Lower availabilities were predicted by the dispersion model than by a segregated distribution model for both compounds. The differences in the predictions were most pronounced for models corresponding to a large variation in solute residence times in the liver. The predictions of the tank-in-series, dispersion model with mixed boundary conditions and dispersion model with Dankwerts boundary conditions were similar over all concentrations studied. Changes in blood flow and protein binding provided little discrimination between the model predictions. It is concluded that micromixing of blood between sinusoids and the anatomical sites of mixing are important determinants of availability when liver eliminating enzymes are partially saturated.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2635740     DOI: 10.1007/bf01062125

Source DB:  PubMed          Journal:  J Pharmacokinet Biopharm        ISSN: 0090-466X


  40 in total

1.  A dispersion model of hepatic elimination: 1. Formulation of the model and bolus considerations.

Authors:  M S Roberts; M Rowland
Journal:  J Pharmacokinet Biopharm       Date:  1986-06

2.  Models of hepatic elimination: comparison of stochastic models to describe residence time distributions and to predict the influence of drug distribution, enzyme heterogeneity, and systemic recycling on hepatic elimination.

Authors:  M S Roberts; J D Donaldson; M Rowland
Journal:  J Pharmacokinet Biopharm       Date:  1988-02

3.  Models of hepatic drug clearance: discrimination between the 'well stirred' and 'parallel-tube' models.

Authors:  A B Ahmad; P N Bennett; M Rowland
Journal:  J Pharm Pharmacol       Date:  1983-04       Impact factor: 3.765

Review 4.  Physiologically based models and strategic experiments in hepatic pharmacology.

Authors:  L Bass; S Keiding
Journal:  Biochem Pharmacol       Date:  1988-04-15       Impact factor: 5.858

5.  Protein binding and hepatic clearance: discrimination between models of hepatic clearance with diazepam, a drug of high intrinsic clearance, in the isolated perfused rat liver preparation.

Authors:  M Rowland; D Leitch; G Fleming; B Smith
Journal:  J Pharmacokinet Biopharm       Date:  1984-04

6.  Effect of sinusoidal perfusion on galactose elimination kinetics in perfused rat liver.

Authors:  S Keiding; E Chiarantini
Journal:  J Pharmacol Exp Ther       Date:  1978-05       Impact factor: 4.030

Review 7.  Functional implications of liver cell heterogeneity.

Authors:  J J Gumucio; D L Miller
Journal:  Gastroenterology       Date:  1981-02       Impact factor: 22.682

8.  Flow dependence of first-order uptake of substances by heterogeneous perfused organs.

Authors:  L Bass
Journal:  J Theor Biol       Date:  1980-09-21       Impact factor: 2.691

9.  An enzyme-distributed system for lidocaine metabolism in the perfused rat liver preparation.

Authors:  K S Pang; J A Terrell; S D Nelson; K F Feuer; M J Clements; L Endrenyi
Journal:  J Pharmacokinet Biopharm       Date:  1986-04

10.  Clinical applicability of current pharmacokinetic models: splanchnic elimination of 5-fluorouracil in cancer patients.

Authors:  P J Robinson; L Bass; S M Pond; M S Roberts; J G Wagner
Journal:  J Pharmacokinet Biopharm       Date:  1988-06
View more
  9 in total

1.  Modeling of hepatic elimination and organ distribution kinetics with the extended convection-dispersion model.

Authors:  M S Roberts; Y G Anissimov
Journal:  J Pharmacokinet Biopharm       Date:  1999-08

2.  Analysis of nonlinear and nonsteady state hepatic extraction with the dispersion model using the finite difference method.

Authors:  A Hisaka; Y Sugiyama
Journal:  J Pharmacokinet Biopharm       Date:  1998-10

3.  A compartmental model of hepatic disposition kinetics: 1. Model development and application to linear kinetics.

Authors:  Yuri G Anissimov; Michael S Roberts
Journal:  J Pharmacokinet Pharmacodyn       Date:  2002-04       Impact factor: 2.745

4.  Residence time distributions of solutes in the perfused rat liver using a dispersion model of hepatic elimination: 1. Effect of changes in perfusate flow and albumin concentration on sucrose and taurocholate.

Authors:  M S Roberts; S Fraser; A Wagner; L McLeod
Journal:  J Pharmacokinet Biopharm       Date:  1990-06

5.  Axial tissue diffusion can account for the disparity between current models of hepatic elimination for lipophilic drugs.

Authors:  L P Rivory; M S Roberts; S M Pond
Journal:  J Pharmacokinet Biopharm       Date:  1992-02

6.  On the degree of solute mixing in liver models of drug elimination.

Authors:  M Weiss
Journal:  J Pharmacokinet Biopharm       Date:  1997-06

7.  Metabolite mean transit times in the liver as predicted by various models of hepatic elimination.

Authors:  G D Mellick; Y G Anissimov; A J Bracken; M S Roberts
Journal:  J Pharmacokinet Biopharm       Date:  1997-08

Review 8.  Drug structure-transport relationships.

Authors:  Michael S Roberts
Journal:  J Pharmacokinet Pharmacodyn       Date:  2010-11-24       Impact factor: 2.745

9.  A physiologically-based flow network model for hepatic drug elimination I: regular lattice lobule model.

Authors:  Vahid Rezania; Rebeccah Marsh; Dennis Coombe; Jack Tuszynski
Journal:  Theor Biol Med Model       Date:  2013-09-05       Impact factor: 2.432

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.